Hello
My name is Henrik Lissau. I am a senior non-clinical programmer at Novo Nordisk.
In my department, we are considering using SASUnit for unit testing of our standard SAS programs.
Since we are a pharmaceutical company, there are certain requirements we must comply with in relation to using open source software.
Therefore, I would like to know if you have any kind of documentation on how SASUnit was tested/validated.
Any information is appreciated. Thanks in advance 😊
Yours sincerely
Henrik Lissau (He/Him)
Senior Non-clinical Programmer
Non-clinical Data Management, R&ED Digital Science & Innovation
4530798078 (direct)
hlis@novonordisk.comhlis@novonordisk.com
Novo Nordisk A/S ǀ Novo Nordisk Park ǀ DK-2760 Måløv ǀ +45 4444 8888 (switchboard) ǀ novonordisk.com
This e-mail (including any attachments) is intended for the addressee(s) stated above only and may contain confidential information protected by law. You are hereby notified that any unauthorised reading, disclosure, copying or distribution of this e-mail or use of information contained herein is strictly prohibited and may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete it immediately hereafter. Thank you.
Hello
My name is Henrik Lissau. I am a senior non-clinical programmer at Novo Nordisk.
In my department, we are considering using SASUnit for unit testing of our standard SAS programs.
Since we are a pharmaceutical company, there are certain requirements we must comply with in relation to using open source software.
Therefore, I would like to know if you have any kind of documentation on how SASUnit was tested/validated.
Any information is appreciated. Thanks in advance 😊
Yours sincerely
Henrik Lissau (He/Him)
Senior Non-clinical Programmer
Non-clinical Data Management, R&ED Digital Science & Innovation
4530798078 (direct)
hlis@novonordisk.comhlis@novonordisk.com
Novo Nordisk A/S ǀ Novo Nordisk Park ǀ DK-2760 Måløv ǀ +45 4444 8888 (switchboard) ǀ novonordisk.com
This e-mail (including any attachments) is intended for the addressee(s) stated above only and may contain confidential information protected by law. You are hereby notified that any unauthorised reading, disclosure, copying or distribution of this e-mail or use of information contained herein is strictly prohibited and may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete it immediately hereafter. Thank you.